AI
Friday, March 26, 2021 6:40:38 AM
https://glioblastoma-drugdevelopment.com/speaker/josh-allen/
'Optimize the Role of Immunotherapy for Treatment of Glioblastoma
Time: 10:20 am
Day: Day One
Details:
Outline the historical and current understanding of the mechanisms of
immune responses against glioblastoma
Discuss the common challenges of designing and evaluating clinical
trials of immunotherapy for glioblastoma
Elucidate the considerations of timing, sequence, and tumor/patient
heterogeneity in developing combination immunotherapy/vaccine trials
for glioblastoma'
Recent NWBO News
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
